Cargando…

Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation

BACKGROUND: Although long-term estrogen (E2) exposure is associated with increased breast cancer (BC) risk, and E2 appears to sustain growth of BC cells that express functional estrogen receptors (ERs), its role in promoting BC stem cells (CSCs) remains unclear. Considering that Gli1, part of the So...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Ying, Wang, Yunshan, Fan, Cong, Gao, Peng, Wang, Xiuwen, Wei, Guangwei, Wei, Junmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057898/ https://www.ncbi.nlm.nih.gov/pubmed/24889938 http://dx.doi.org/10.1186/1476-4598-13-137

Ejemplares similares

Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer
por: FAN, CONG, et al.
Publicado: (2015)

Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer
por: Fan, Cong, et al.
Publicado: (2023)

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
por: Deng, Hao, et al.
Publicado: (2014)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
por: Shi, Liang, et al.
Publicado: (2015)

Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells
por: Wang, Yunshan, et al.
Publicado: (2015)

Obesity-Altered Adipose Stem Cells Promote ER(+) Breast Cancer Metastasis through Estrogen Independent Pathways
por: Sabol, Rachel A., et al.
Publicado: (2019)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2015)

Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)

The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
por: Rodriguez, David, et al.
Publicado: (2019)

Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells
por: Hsu, P-Y, et al.
Publicado: (2016)

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
por: Batra, Atul, et al.
Publicado: (2020)

DEAD-box RNA Helicase 39 Promotes Invasiveness and Chemoresistance of ER-positive Breast Cancer
por: Wang, Xiudi, et al.
Publicado: (2020)

An estrogen receptor (ER)‐related signature in predicting prognosis of ER‐positive breast cancer following endocrine treatment
por: Tang, Jianing, et al.
Publicado: (2019)

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
por: Groenendijk, Floris H., et al.
Publicado: (2019)

Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines
por: Kwon, Yeon-Jin, et al.
Publicado: (2011)

YB-1 interplays with ERα to regulate the stemness and differentiation of ER-positive breast cancer stem cells
por: Yang, Fan, et al.
Publicado: (2020)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis
por: Zeng, Hao, et al.
Publicado: (2015)

Novel ERα positive breast cancer model with estrogen independent growth in the bone microenvironment
por: Capietto, Aude-Hélène, et al.
Publicado: (2016)

Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)

Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
por: Pham, Thu Ha, et al.
Publicado: (2021)

GLI3 Promotes Invasion and Predicts Poor Prognosis in Colorectal Cancer
por: Shen, Mingyang, et al.
Publicado: (2021)

SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination
por: Li, Ce, et al.
Publicado: (2019)

Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues
por: Poola, Indira, et al.
Publicado: (2007)

Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
por: Sarfstein, Rive, et al.
Publicado: (2010)

Reply to Letter to Editor: “HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?”
por: Li, Shuai, et al.
Publicado: (2020)

Identification of Estrogen Response Element in Aquaporin-3 Gene that Mediates Estrogen-induced Cell Migration and Invasion in Estrogen Receptor-positive Breast Cancer
por: Huang, Yi-Ting, et al.
Publicado: (2015)

An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
por: Zhou, Xin, et al.
Publicado: (2014)

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
por: Rees, Michael, et al.
Publicado: (2020)

Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry
por: Semaan, Suzan M., et al.
Publicado: (2012)

Estrogen receptor variant ER‐α36 promotes tamoxifen agonist activity in glioblastoma cells
por: Qu, Chao, et al.
Publicado: (2019)

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
por: Narbe, Ulrik, et al.
Publicado: (2019)

Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer
por: Di Cello, Francescopaolo, et al.
Publicado: (2013)

HER2 and ERβ2 downregulate estrogen-responsive element-mediated transcription activity of ERα-positive cells in response to estrogen stimulation
por: Park, B-W, et al.
Publicado: (2005)

MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells
por: Lin, Jun, et al.
Publicado: (2021)

Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration
por: Peng, Jing, et al.
Publicado: (2021)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2017)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2017)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0i1hsv1tinlpiseii8ct2dce3g